NCT02748824已完成不适用
Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal
Association for Innovation and Biomedical Research on Light and Image1 个研究点 分布在 1 个国家目标入组 5,996 人开始时间: 2016年7月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 5,996
- 试验地点
- 1
- 主要终点
- Phenotypic classification of AMD in the five-year clinical visit. Comparison of this classification with the grading of 5 years ago.
研究概览
简要总结
To assess the five-year incidence of AMD in a population from the central region of Portugal, previously phenotypically characterized.
详细描述
Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) between 2009 and 2013 will attend a single visit, after giving informed consent.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) and that were phenotyped;
- •Subjects capable of understanding the information about the study and to give their informed consent to enter the study;
- •Subjects willing and able to comply with the study procedures.
排除标准
- •Not applicable
结局指标
主要结局
Phenotypic classification of AMD in the five-year clinical visit. Comparison of this classification with the grading of 5 years ago.
时间窗: 5 years
次要结局
- Risk factors: Demographic, Medical history, Ophthalmologic history, Family history of AMD, Systemic comorbidities and medication, Nutritional and Lifestyle habits. Signs of AMD on the multimodal evaluation.(5 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing FactorsElderly French PopulationAge-related Macular DegenerationNCT01918553University Hospital, Bordeaux516
已完成
不适用
Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.Macular DegenerationNCT04988178Brugmann University Hospital34
已完成
不适用
Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPAAge Related Macular DegenerationParkinson DiseaseNCT03415984Fondation Ophtalmologique Adolphe de Rothschild133
已完成
不适用
Development of a Device to Measure Dark AdaptationAge-Related Macular DegenerationMacular DegenerationNCT02090751University of Manchester40
已完成
不适用
Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU BrugmannAge-related Macular DegenerationNCT04891835Laurence Postelmans36